Kinled Holding
Hong Kongkinled.com
Overview
Kinled Holding is a family office investment firm that holds a diversified portfolio of assets through direct and fund investments in innovative businesses across the Life Science, Financial, and Digital Technology sectors. They focus on financing deep technological breakthroughs in advanced medical devices, robotics, precision medicine, drug discovery, and neuromodulation. Kinled is a Founding Partner/Director/Limited Partner in ten independent funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lumicell Diagnostics | Jul 2023 | Series D | Co-investor |
| Nanoflex Robotics | Feb 2023 | Series A | Co-investor |
| Bricksave | Jan 2023 | Series A | Co-investor |
| IntellCRE | May 2022 | Pre Seed | Co-investor |
| Eirion | Mar 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.